An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan

In Taiwan, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs), gefitinib, erlotinib, and afatinib are served as first-line therapy for non-small lung cell cancer (NSCLC) patients with EGFR sensitizing mutations. However, the majority of patients who initially respond to E...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shang-Gin, Chiang, Chi-Lu, Liu, Chien-Ying, Wang, Chin-Chou, Su, Po-Lan, Hsia, Te-Chun, Shih, Jin-Yuan, Chang, Gee-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498675/
https://www.ncbi.nlm.nih.gov/pubmed/33014788
http://dx.doi.org/10.3389/fonc.2020.01481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498675/
https://www.ncbi.nlm.nih.gov/pubmed/33014788
http://dx.doi.org/10.3389/fonc.2020.01481

Ejemplares similares